![]() |
![]() |
Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
Bank Loan Ratings | 29.98 | ACUITE C | Downgraded | Issuer not co-operating* | - |
Bank Loan Ratings | 0.02 | - | ACUITE A4 | Downgraded | Issuer not co-operating* |
Total Outstanding | 30.00 | - | - |
Total Withdrawn | 0.00 | - | - |
* The issuer did not co-operate; based on best available information. |
Rating Rationale |
Acuité has downgraded its long-term rating to 'ACUITE C' (read as ACUITE C) from 'ACUITE BB-' (read as ACUITE double B minus) and its short-term rating to 'ACUITE A4' (read as ACUITE A four) from 'ACUITE A4+' (read as ACUITE A four plus) to the Rs.30.00 crore bank facilities of Seutic Labs Private Limited (SLPL).
The rating is now flagged as “Issuer Not-Cooperating” and is based on the best information available. The downgrade is based on the CRIF Highmark report, which shows delays in the unsecured business loan account in November 2024 and also in the cash credit account that shows continous overdrawls of 34 days in October 2024. |
About the Company |
Seutic Labs Private Limited was incorporated as a private limited company in 2016 and promoted by Mr. Valivarthi Siva Vara Prasad (holds 60% stake) and his wife Padma Valivarthi (holds 40% stake). The company is engaged in the manufacture bulk drug intermediates. The same have applications in segments of cardiovascular and antibiotics. SLPL has its manufacturing facility at KIADB Industrial Area, Humnabad, Bidar, Karnataka with an installed capacity of 50 Metric Tons Per annum.
|
Unsupported Rating |
Not Applicable |
Non-cooperation by the issuer/borrower |
Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date.
Acuité believes that information risk is a critical component in such ratings, and non-cooperation by the issuer along with unwillingness to provide information could be a sign of potential deterioration in its overall credit quality. This rating is, therefore, being flagged as “Issuer not-cooperating”, in line with prevailing SEBI regulations and Acuité’s policies. |
Limitation regarding information availability |
The rating is based on information available from sources other than the issuer/borrower (in the absence of information provided by the issuer/borrower). Acuité endeavoured to gather information about the entity/industry from the public domain. Therefore, Acuité cautions lenders and investors regarding the use of such information, on which the indicative credit rating is based.
|
Rating Sensitivities |
No information provided by the issuer / available for Acuite to comment upon |
Liquidity Position |
No information provided by the issuer / available for Acuite to comment upon |
Outlook: Not Applicable |
|
Other Factors affecting Rating |
None |
Particulars | Unit | FY 23 (Provisional) | FY 22 (Actual) |
Operating Income | Rs. Cr. | 120.75 | 137.41 |
PAT | Rs. Cr. | 3.92 | 0.62 |
PAT Margin | (%) | 3.24 | 0.45 |
Total Debt/Tangible Net Worth | Times | 2.43 | 2.87 |
PBDIT/Interest | Times | 2.62 | 1.74 |
Status of non-cooperation with previous CRA |
Not Applicable |
Any other information |
None |
Applicable Criteria |
• Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm • Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm • Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm |
Note on complexity levels of the rated instrument |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* The issuer did not co-operate; based on best available information. |
Contacts |
About Acuité Ratings & Research |
© Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |